Interview: EMA’s Peter Arlett provides update on DARWIN EU

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsPharmaceuticalsPharmacovigilanceRegulatory Intelligence/PolicyUnited States